Registered number
07927807
JGS Medical Limited
Filleted Accounts
31 January 2026
JGS Medical Limited
Registered number: 07927807
Balance Sheet
as at 31 January 2026
Notes 2026 2025
£ £
Fixed assets
Tangible assets 3 - 40
Investments 4 87,535 87,535
87,535 87,575
Current assets
Debtors 5 12,000 12,000
Cash at bank and in hand 7,250 8,325
19,250 20,325
Creditors: amounts falling due within one year 6 (14,713) (13,653)
Net current assets 4,537 6,672
Net assets 92,072 94,247
Capital and reserves
Called up share capital 100 100
Profit and loss account 91,972 94,147
Shareholder's funds 92,072 94,247
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr J Ganeshalingam
Director
Approved by the board on 23 October 2026
JGS Medical Limited
Notes to the Accounts
for the year ended 31 January 2026
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Office equipment over 4 years
Investment properties
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently, it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss. Where fair value cannot be achieved without undue cost or effort, investment property is accounted for as tangible fixed assets.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Employees 2026 2025
Number Number
Average number of persons employed by the company 1 0
3 Tangible fixed assets
Office equipment
£
Cost
At 1 February 2025 1,680
Disposals (1,680)
At 31 January 2026 -
Depreciation
At 1 February 2025 1,640
On disposals (1,640)
At 31 January 2026 -
Net book value
At 31 January 2026 -
At 31 January 2025 40
4 Investments
Investment
property
£
Cost
At 1 February 2025 87,535
At 31 January 2026 87,535
The fair value adjustment of the investment property has been carried out by the director. The director having suitable knowledge and qualification considered the above valution to be a fair reflection of the value of the investment property as at 31 January 2026.
5 Debtors 2026 2025
£ £
Other debtors 12,000 12,000
6 Creditors: amounts falling due within one year 2026 2025
£ £
Trade creditors 180 -
Other creditors 14,533 13,653
14,713 13,653
7 Other information
JGS Medical Limited is a private company limited by shares and incorporated in England. Its registered office is:
311 Regents Park Road
London
N3 1DP
JGS Medical Limited 07927807 false 2025-02-01 2026-01-31 2026-01-31 VT Final Accounts September 2026 Dr J Ganeshalingam No description of principal activity 07927807 2024-02-01 2025-01-31 07927807 core:WithinOneYear 2025-01-31 07927807 core:ShareCapital 2025-01-31 07927807 core:RetainedEarningsAccumulatedLosses 2025-01-31 07927807 2025-02-01 2026-01-31 07927807 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 07927807 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 07927807 bus:Director40 2025-02-01 2026-01-31 07927807 1 2025-02-01 2026-01-31 07927807 2 2025-02-01 2026-01-31 07927807 core:PlantMachinery 2025-02-01 2026-01-31 07927807 countries:England 2025-02-01 2026-01-31 07927807 bus:FRS102 2025-02-01 2026-01-31 07927807 bus:FilletedAccounts 2025-02-01 2026-01-31 07927807 2026-01-31 07927807 core:WithinOneYear 2026-01-31 07927807 core:ShareCapital 2026-01-31 07927807 core:RetainedEarningsAccumulatedLosses 2026-01-31 07927807 core:PlantMachinery 2026-01-31 07927807 2025-01-31 07927807 core:PlantMachinery 2025-01-31 iso4217:GBP xbrli:pure